Loading insider details...
Beta
Latest Form 4 (Sep 25, 2026): Grant/Award of 36,000 COAG shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 25, 2026 | Hemab Therapeutics Holdings, Inc. (COAG) | Grant/Award | 36,000 | n/a |
| May 26, 2026 | SPRUCE BIOSCIENCES, INC. (SPRB) | Grant/Award | 1,700 | n/a |
| May 14, 2026 | Apellis Pharmaceuticals, Inc. (APLS) | Tender of Shares | 17,051 | n/a |
| Jan 5, 2026 | Apellis Pharmaceuticals, Inc. (APLS) | Grant/Award | 7,961 | n/a |
| Dec 15, 2025 | SPRUCE BIOSCIENCES, INC. (SPRB) | Grant/Award | 3,400 | n/a |
| Jan 10, 2025 | Apellis Pharmaceuticals, Inc. (APLS) | Grant/Award | 9,090 | n/a |